InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Chen Hubert C, Directeur Médical. Officer active across 2 companies, notably Metacrine, Inc.. In total, 6 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €10k. Activity tracked since 20 May 2021. The latest transaction was disclosed on 1 January 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Chen Hubert C
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
7,500 股0Common StockSEC:0001209191-24-000326:0
7,500 股0Common StockSEC:0001209191-23-051484:0
74,257 股@ US$1.01100.0% 占其流量Common StockSEC:0001209191-23-044282:0
7,500 股0Common StockSEC:0001209191-23-040978:0
7,500 股0Common StockSEC:0001209191-23-023076:0
3,289 股@ US$3.60100.0% 占其流量Common StockSEC:0001209191-21-034595:0
标准退出：2021年8月18日 (T+90)
6 条申报中的 6 条
About Chen Hubert C
Chen Hubert C is the Chief Medical Officer at Metacrine, Inc. He oversees the medical operations of the company, ensuring efficiency and compliance of processes. His role is crucial for product development and innovation in the biopharmaceutical sector.
